Nara Organics is relaunching its infant formula in the United States using a supply chain based entirely in the European Union. The decision follows a botulism outbreak that sickened four children and triggered a nationwide recall in June.
The pivot to European Union dairy after the April 2025 break
Nara Organics announced on August 27 that it will return to the American market by abandoning its domestic dairy sources. According to the report, Nara Organics ended its parrtnerships with American dairy suppliers in April 2025 to transition toward European sourcing. This strategic shift aims to create a "cleaner separation" from the specific suppliers linked to recent health crises.
This move reflects a broader trend of companies seeking higher regulatory stability in the EU when domestic systems fail. For Nara Organics, the risk of continuing with the previous chain was too high given the severity of the botulism cases and the fragility of infant health.
Four children hospitalized and the Organic West Milk connection
The decision to pivot follows a multistate outbreak that resulted in the hospitalization of four children. as reported, the FDA identified cases in Pennsylvania, California, and Washington, eventually declaring the outbreak over. The investigation revealed a critical link: clinical samples from an affected infant matched those from the 2025 ByHeart outbreak.
Investigators determined that the common thread between these separate incidents was milk supplied by Organic West Milk and processed by Dairy Farmers of America. This suggests a systemic vulnerability in the raw milk supply that affected multiple brands,not just Nara Organics, pointing to a deeper issue within the domestic dairy infrastructure.
New Clostridium botulinum protocols for Target and online sales
To prevent a recurrence, Nara Organics is implementing rigorous Clostridium botulinum testing prootocols.. These tests are designed to detect contamination before the powdered formula reaches retail shelves or online customers. The previously recalled products, which were sold at Target and online with best-by dates extending into 2027, have been ordered for disposal by the FDA.
The urgency of these safety measures is underscored by the biological vulnerability of infants. Since nearly 80 percent of parents use formula at some point, and one in five babies uses it in their first few days, any failure in sterilization can lead to respiratory failure or loss of head control.
The unresolved root cause of the Dairy Farmers of America contamination
Despite the relaunch plans, a significant gap remains in the FDA's findings regarding the Dairy Farmers of America processing chain. Federal regulators have stated there is currently insufficient evidence to determine if the milk was contaminated before it reached the plant or during the drying process.
This leaves a critical question unanswered: if the contamination occurred during the drying process, does the risk persist for other brands using similar facilities? While Nara Organics is escaping the problem by moving to the EU, the FDA's root cause investigation remains ongoing, leaving the domestic industry in a state of uncertainty.
Comments 0